KIM DONG (Chief Financial Officer) exercised options at UROGEN PHARMA LTD.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/2/2024ACC: 0001437749-24-003014
Officer· Chief Financial Officer
Since Mar 2022
+12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
15.33K acquired · 3.33K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+3.33K
Price / share
—
Trade value
—
% of position
14.3%
1/31/2024
23.25K→26.59K
Total
Net shares
+3.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/31/2024 | M · Option Exercise | +3.33K | — | — | 14.3% | 23.25K | 26.59K |
| Total | +3.33K | $0.00 | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Ordinary Shares
3.33K shares
Shares
−3.33K
Strike price
Held after
6.67K
Exercisable
—
1/31/2024
Restricted Stock Units
Direct
Converts to
Ordinary Shares
12K shares
Shares
+12K
Strike price
Held after
12K
Exercisable
—
1/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares3.33K shares | 1/31/2024 | M · Option Exercise | −3.33K | — | 6.67K | |
| Restricted Stock Units Direct | Ordinary Shares12K shares | 1/31/2024 | A · Award | +12K | — | 12K |